Sunny Kumar Partner
Sunny Kumar is a Partner at GSR Ventures, where he focuses on investments in early-stage companies applying artificial intelligence and machine learning technologies to the healthcare sector. Sunny is a physician as well as a published medical researcher with a focus on applying informatics and artificial intelligence to translational medicine in the fields of neurosurgery and gene therapy. He is a serial entrepreneur and most recently founded a company to reduce readmissions for high-risk patients with chronic diseases using voice-enabled natural language processing technology. Sunny received a BS in Molecular Biology from Yale University, an MD from Stanford University School of Medicine, and an MBA from Stanford University Graduate School of Business.
Kinsa forecasts the spread of contagious illness through a smart thermometer network that enables faster and more precise detection and response to outbreaks like Covid-19.
Deep 6 AI applies artificial intelligence and natural language processing to all clinical data to find eligible patients for clinical trials faster, accelerating recruitment exponentially and getting cures to the people who need them more quickly.
Medable is on a mission to reduce clinical trial timelines by 50 percent. The company’s global decentralized trial platform streamlines design, recruitment, retention and data quality, replacing siloed systems with integrated digital tools, data and interfaces to accelerate trial execution. Medable connects patients, sites and clinical trial teams to improve patient access, experience, and outcomes.
245 Lytton Ave, STE. 350, Palo Alto, CA 94301, USA
Tel: +1 (650) 331-7300
©2020 GSR Ventures. All Rights Reserved.